infexn®-NGS uses the latest long-read sequencing technology for high-throughput detection of all microbial populations in a clinical samples. The standardized workflow is applicable to diverse clinical samples and Ω ID™ automates data analysis and generates an easy-to-read report within 24 hours of receiving a sample.

Blood
Sterile body fluids
Respiratory samples
Urine samples
Direct‑from‑sample sequencing
Clinically validated and field‑tested workflow
Applicable for most clinical sample types
Automated data analysis
Proprietary bioinformatics pipeline
Actionable, easy‑to‑read report in 24 hours
infexn® is powered by HaystackAnalytics’ proprietary products Universal ID™ and Ω ID™.